Filipa Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Filipa Santos has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Alliny Cristiny da Silva Bastos
16Division of Oncology, Section of Medical Oncology, Washington University School of Medicine (WashU Medicine), St. Louis, Missouri
47 shared publications - António Syder Queiroz
Medical Oncology Department, Unidade Local de Saúde de Santa Maria, Lisboa, Portugal
47 shared publications - Brian Andrew Van Tine
Washington University in St. Louis
47 shared publications - Cecília Melo-Alvim
Department of Medical Oncology, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal
47 shared publications - Daniel Martins Jordão
Faculdade de Medicina da Universidade de Lisboa, Universidade de Lisboa, Lisboa, Portugal
47 shared publications - Dolores López-Presa
Pathology Department, Unidade Local de Saúde de Santa Maria, Lisboa, Portugal
47 shared publications
Latest Publications
- Open Access
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 8 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 8 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
- Open Access
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 24 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 24 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 24 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 24 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
- Open Access
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 17 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 17 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 17 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 17 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
- Open Access
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 2 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 2 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
- Open Access
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Figure 4 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
SDHB IHC in sarcomas: Three-tier score for SDH immunostaining intensity. A and B with weak and focal granular cytoplasmic immunostaining (score 1); C and D with diffuse intermediate granular cytoplasmic immunostaining (score 2); and E and F with diffuse and strong granular cytoplasmic immunostaining (score 3).
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 4 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
SDHB IHC in sarcomas: Three-tier score for SDH immunostaining intensity. A and B with weak and focal granular cytoplasmic immunostaining (score 1); C and D with diffuse intermediate granular cytoplasmic immunostaining (score 2); and E and F with diffuse and strong granular cytoplasmic immunostaining (score 3).
- Open Access
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 20 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 20 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 20 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 20 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
- Open Access
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Figure 2 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Within the UPS population, overexpression of SDHB is significantly correlated with shorter OS, using a Kaplan–Meier model (A,P value < 0.05) and also using a Cox proportional hazards model (B,P value < 0.05), and also with a shorter OS from the date of first metastasis, using a Kaplan–Meier model (C,P value < 0.05) and also using a Cox proportional hazards model (D,P value < 0.05). *, P value < 0.05.
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 2 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Within the UPS population, overexpression of SDHB is significantly correlated with shorter OS, using a Kaplan–Meier model (A,P value < 0.05) and also using a Cox proportional hazards model (B,P value < 0.05), and also with a shorter OS from the date of first metastasis, using a Kaplan–Meier model (C,P value < 0.05) and also using a Cox proportional hazards model (D,P value < 0.05). *, P value < 0.05.
- Open Access
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 12 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 12 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
- 30 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 12 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma
Supplementary Figure 12 from Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma